Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Quinkler

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 4, 2019
Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein SamplingGian Paolo Rossi, Giacomo Rossitto, Laurence Amar, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2019
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and LateralizationGiacomo Rossitto, Laurence Amar, Michel Azizi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
European Journal of Endocrinology|February 2, 2023
International multicenter survey on screening and confirmatory testing in primary aldosteronismMitsuhide Naruse, Masanori Murakami, Takuyuki Katabami, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical CancerAnne Jouinot, Guillaume Assie, Rossella Libe, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational studyMassimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesisVasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
Plos One|March 12, 2014
Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohortsAnna L Mitchell, Katie D R Macarthur, Earn H Gan, et al.
Annals of Internal Medicine|January 3, 2022
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter StudyAlessandro Prete, Anuradhaa Subramanian, Irina Bancos, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Hypertension (Dallas, Tex. : 1979)|September 4, 2019
Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein SamplingGian Paolo Rossi, Giacomo Rossitto, Laurence Amar, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2019
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and LateralizationGiacomo Rossitto, Laurence Amar, Michel Azizi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal IncidentalomaLetizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
European Journal of Endocrinology|February 2, 2023
International multicenter survey on screening and confirmatory testing in primary aldosteronismMitsuhide Naruse, Masanori Murakami, Takuyuki Katabami, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical CancerAnne Jouinot, Guillaume Assie, Rossella Libe, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational studyMassimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesisVasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
Plos One|March 12, 2014
Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohortsAnna L Mitchell, Katie D R Macarthur, Earn H Gan, et al.
Annals of Internal Medicine|January 3, 2022
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter StudyAlessandro Prete, Anuradhaa Subramanian, Irina Bancos, et al.
Pageof 21